Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

195

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	826,463 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%		Injectable solution	4,031,528 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	4,143,943 L.L
L03AB07	CINNOVEX	BioTech	Interferon beta-1a - 30mcg	30mcg	Injectable solution	39,804,728 L.L
A03BB01	HISCOPINE (HYOSCINE BUTYL BROMIDE INJECTION)	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	3,217,159 L.L
B05AA01	HUMAN ALBUMIN "OCTAPHARMA" 20%	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	3,985,356 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 135mcg/0.5ml	135mcg/0.5ml	Injectable solution	15,796,329 L.L
L04AC05	USTEKIREL	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
B05AA01	HUMAN ALBUMIN 20% SOLUTION	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	5,566,628 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	18,197,019 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
B05AA01	HUMAN ALBUMIN BEHRING 20%, LOW SALT	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	519,736 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	60,563,068 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
A12CX	PHOSPHATE DIPOTASSIQUE RENAUDIN	G	Phosphate dipotassique - 174.20mg/ml	174.20mg/ml	Injectable solution	1,189,301 L.L
B05AA01	PLASBUMIN-20 ALBUMIN (HUMAN)	BioHuman	Albumin human - 20%	20%	Injectable solution	3,641,813 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
N02AA01	MORPHINE (CHLORHYDRATE) RENAUDIN	G	Morphine HCl - 1mg/ml	1mg/ml	Injectable solution	626,231 L.L
B05AA01	UMAN ALBUMIN	BioHuman	Albumin human - 20g/100ml	10g/50ml	Injectable solution	3,598,810 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
N02AA01	CHLORHYDRATE DE MORPHINE RENAUDIN	G	Morphine HCl - 20mg/ml	20mg/ml	Injectable solution	1,100,607 L.L
N05CM18	PRECEDEX (DEXMEDETOMIDINE)	B	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable solution	19,441,512 L.L
B05AA01	VIALEBEX	BioHuman	Albumin human - 200g/L	200g/L	Injectable solution	3,417,391 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	166,708 L.L
L03AX13	GLITAXON	G	Glatiramer acetate - 20mg/ml	20mg/ml	Injectable solution	10,146,988 L.L

...

195